• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑色素瘤:化疗反应中的性别差异?

Malignant melanoma: sex differences in response to chemotherapy?

作者信息

Rampen F H

出版信息

Eur J Cancer Clin Oncol. 1982 Jan;18(1):107-10. doi: 10.1016/0277-5379(82)90033-5.

DOI:10.1016/0277-5379(82)90033-5
PMID:7200889
Abstract

From studying cell kinetic parameters it is demonstrated that both males and females with metastatic melanoma respond favourably to various chemotherapy schedules. Male patients have a shorter doubling time (DT) of pulmonary secondaries prior to chemotherapy compared to females, which seems to give them a less favorable starting point. Also, the DT of lung metastases of males after chemotherapy is less favourable than that of females. However, a significant difference in DT is noticed between measurements prior to and after the institution of chemotherapy in both sexes. It is concluded that the alleged sex differences in response to chemotherapy may be an artifact due to differences in tumor growth kinetics between males and females.

摘要

通过对细胞动力学参数的研究表明,患有转移性黑色素瘤的男性和女性对各种化疗方案均有良好反应。与女性相比,男性患者在化疗前肺部继发性肿瘤的倍增时间(DT)较短,这似乎使他们的起始点不太有利。此外,男性化疗后肺转移灶的DT比女性更不理想。然而,两性在化疗开始前后的测量中,DT存在显著差异。得出的结论是,所谓的化疗反应性别差异可能是由于男性和女性肿瘤生长动力学的差异而产生的假象。

相似文献

1
Malignant melanoma: sex differences in response to chemotherapy?恶性黑色素瘤:化疗反应中的性别差异?
Eur J Cancer Clin Oncol. 1982 Jan;18(1):107-10. doi: 10.1016/0277-5379(82)90033-5.
2
Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.晚期黑色素瘤的联合化疗(达卡巴嗪、卡莫司汀、顺铂和他莫昔芬)。
Singapore Med J. 1996 Apr;37(2):165-7.
3
Prognostic factors in metastatic malignant melanoma: The Southeastern Cancer Study Group Experience.转移性恶性黑色素瘤的预后因素:东南癌症研究组的经验
Cancer. 1982 May 15;49(10):2192-6. doi: 10.1002/1097-0142(19820515)49:10<2192::aid-cncr2820491035>3.0.co;2-r.
4
[Growth dynamics of malignant melanomas. Determination of tumor doubling time based on morphometric measurements of roentgen images of lung metastases].[恶性黑色素瘤的生长动力学。基于肺转移瘤X线图像形态测量法测定肿瘤倍增时间]
Z Hautkr. 1988 Jun 15;63(6):481-7.
5
[Quantitative growth characteristics of pulmonary metastases in cutaneous melanoma].
Vopr Onkol. 2003;49(6):730-3.
6
Malignant melanoma: an androgen-dependent tumour?恶性黑色素瘤:一种雄激素依赖性肿瘤?
Lancet. 1980 Mar 15;1(8168 Pt 1):562-4. doi: 10.1016/s0140-6736(80)91055-7.
7
[Treatment of disseminated variants of skin melanoma].[皮肤黑色素瘤播散性变种的治疗]
Vopr Onkol. 1981;27(11):47-50.
8
Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.在覆盖皮肤外用咪喹莫特后,黑色素瘤内部转移灶消退。
J Drugs Dermatol. 2011 Mar;10(3):302-5.
9
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.丙卡巴肼联合长春新碱、双氯乙基亚硝脲及咪唑甲酰胺二甲基三氮烯治疗转移性恶性黑色素瘤的临床试验
Med Pediatr Oncol. 1975;1(2):107-11. doi: 10.1002/mpo.2950010205.
10
Palliation of skeletal melanoma metastases with isolated limb perfusion chemotherapy.
Dermatol Surg. 2006 Sep;32(9):1199-201. doi: 10.1111/j.1524-4725.2006.32266.x.

引用本文的文献

1
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer.三萜类化合物CDDO-甲酯可减轻既定肺癌临床前小鼠模型中的肿瘤负担,重编程免疫微环境,并预防化疗诱导的毒性。
Antioxidants (Basel). 2024 May 21;13(6):621. doi: 10.3390/antiox13060621.
2
Sex Differences in Soft Tissue Sarcoma: Incidence, Clinicopathological Profile, Survival, and Costs.软组织肉瘤的性别差异:发病率、临床病理特征、生存和费用。
J Womens Health (Larchmt). 2023 Nov;32(11):1257-1264. doi: 10.1089/jwh.2023.0019. Epub 2023 Oct 11.
3
How inclusive are cell lines in preclinical engineered cancer models?
临床前工程化癌症模型中的细胞系有多大包容性?
Dis Model Mech. 2022 May 1;15(5). doi: 10.1242/dmm.049520. Epub 2022 Jun 1.
4
Sexual Differentiation Specifies Cellular Responses to DNA Damage.性分化决定细胞对 DNA 损伤的反应。
Endocrinology. 2021 Nov 1;162(11). doi: 10.1210/endocr/bqab192.
5
Sex differences in cancer mechanisms.癌症机制中的性别差异。
Biol Sex Differ. 2020 Apr 15;11(1):17. doi: 10.1186/s13293-020-00291-x.
6
Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results.放射治疗是脉络膜黑色素瘤的合理治疗方法吗?已发表结果分析。
Br J Ophthalmol. 1987 May;71(5):348-52. doi: 10.1136/bjo.71.5.348.